Physician profile
Ashley Mueller
NPI 1770124208
$1,113.55
in general payments reported to CMS, 2019-2025
10 companies · $225 in 2025
The $225 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $216 · 2022: $191 · 2023: $246 · 2024: $237 · 2025: $225.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $707.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $706.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $374.47 | 2023-2025 | Krystexxa, Tavneos |
| Arcutis Biotherapeutics, INC. | $120.87 | 2023 | |
| E.R. Squibb & Sons, L.L.C. | $112.56 | 2021 | |
| Ironshore Pharmaceuticals INC. | $111.56 | 2024 | |
| Glaxosmithkline, LLC. | $107.10 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $103.32 | 2021 | |
| Novartis Pharmaceuticals Corporation | $83.91 | 2022 | |
| Collegium Pharmaceutical, INC. | $59.61 | 2025 | Jornay Pm |
| Ars Pharmaceuticals Operations, INC. | $22.40 | 2025 | Neffy |
| Paratek Pharmaceuticals, INC. | $17.75 | 2025 | Nuzyra |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashley Mueller listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.